News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Intercept's Ocaliva approved in EU for liver disease Potential liver blockbuster gets EU licence.
News NICE rejects Shire pancreatic cancer drug Onivyde not eligible for Cancer Drugs Fund, says NICE.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
